BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,915.00
-10.00 (-0.25%)
At close: Aug 28, 2025
-0.25%
Market Cap32.02B
Revenue (ttm)17.30B
Net Income (ttm)-1.63B
Shares Out8.18M
EPS (ttm)-198.73
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume11,477
Average Volume29,693
Open3,910.00
Previous Close3,925.00
Day's Range3,860.00 - 4,045.00
52-Week Range2,750.00 - 4,820.00
Beta1.22
RSI64.31
Earnings DateAug 14, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.